Loading
LB
Lunai Bioworks Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 20 May 2022.
Lunai Bioworks Inc.: what insiders have been doing
Lunai Bioworks Inc. is a listed company. Filings by its managers are published through SEC (Form 4). Lunai Bioworks Inc. has had no insider filing for more than a year; the last one goes back to 12 March 2025.
The full history, which starts in 2022, counts 1 purchase against 11 sales.
Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
34
Thresholds
n/a
Buy Volume
€954,860
1 ops. · all time
Sell Volume
€1M
11 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2012FY ended March 2012 · cache
Income statement
Gross profitUS$32.5k
Net income-US$154.1M
Last declaration on 12 March 2025
Declarations34 total
350,000 sharesCommon StockSEC:0001214659-25-004233:0
250,000 shares0Common StockSEC:0001731122-25-000295:0
250,000 shares0Common StockSEC:0001731122-24-001669:0
1,114 shares@ US$1.300.4% of flowCommon StockSEC:0001214659-24-017879:0
833,333 shares0Common StockSEC:0001731122-24-001325:0
2,000,000 sharesCommon StockSEC:0001213900-24-070297:0
2,000,000 sharesCommon StockSEC:0001213900-24-068233:0
16,362 shares@ US$1.466.9% of flowCommon StockSEC:0001214659-24-012745:0
21,954 shares@ US$1.418.9% of flowCommon StockSEC:0001214659-24-012571:0
4,630 shares@ US$1.532.1% of flowCommon StockSEC:0001214659-24-012367:0
50,000 shares@ US$1.5122.0% of flowCommon StockSEC:0001214659-24-012082:0
1,853,517 sharesCommon StockSEC:0001213900-24-059029:0
60,000 shares@ US$1.5627.4% of flowCommon StockSEC:0001214659-24-011987:0
20,000 shares@ US$1.589.3% of flowCommon StockSEC:0001214659-24-011566:0
50,000 shares@ US$1.5823.1% of flowCommon StockSEC:0001214659-24-011150:0
471,699 shares@ US$0.53100.0% of flowCommon StockSEC:0001731122-24-000292:0
500,000 shares0Common StockSEC:0001213900-24-015328:1
500,000 shares0Common StockSEC:0001213900-24-015328:2
3,436,190 sharesCommon StockSEC:0001213900-24-015328:0
701,260 sharesCommon StockSEC:0001731122-24-000254:0
1,000,000 shares0Common StockSEC:0001731122-23-002098:0
1,886,794 shares@ US$0.5332.6% of flowCommon StockSEC:0001731122-23-001221:0
877,193 shares@ US$1.1433.5% of flowCommon StockSEC:0001731122-23-000444:0
17,545,283 sharesCommon StockSEC:0001214659-23-001671:0
1,216,467 sharesCommon StockSEC:0001214659-23-001677:0
25 of 34 declarations
About Lunai Bioworks Inc.
RENOVARO INC. is a company listed on the XNAS market. It specializes in the field of innovation and financial technologies.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
